ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Prognostic Tools to Choose Candidates for Successful Desensitization.

    D. Pinelli,1 A. Zachary,2 J. Friedewald,1 M. Leffell,2 D. Lucas,2 R. Montgomery,2 A. Tambur.1

    1Northwestern University, Chicago, IL; 2Johns Hopkins, Baltimore, MD

    Antibodies to donor HLA antigens are a barrier to solid organ transplantation. Strategies to desensitize patients have improved, but the ability to predict response to…
  • 2017 American Transplant Congress

    Hepatic Artery and Biliary Complications in Liver Transplant Recipients with Radioembolization Bridging Treatment for Hepatocellular Carcinoma.

    S. Radunz,1 J. Treckmann,1 F. Saner,1 S. Müller,2 J. Theysohn,3 A. Paul,1 T. Benkö.1

    1General, Visceral and Transplant Surgery, University Hospital Essen, Essen, Germany; 2Nuclear Medicine, University Hospital Essen, Essen, Germany; 3Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany

    Locoregional treatments are commonly applied in hepatocellular carcinoma (HCC) patients as a bridge to liver transplantation to prevent tumor progression during waiting time. We hypothesized…
  • 2017 American Transplant Congress

    Outcomes Following Transplantation for Hepatocellular Carcinoma.

    P. Tabrizian, K. Nakazawa, J. Prigoff, M. Schwartz, S. Florman.

    Transplant, Recanati/Miller Transplantation Institute, New York, Ny

    Objectives: To examine the prognostic features and outcomes of patients undergoing transplantation for hepatocellular carcinoma (HCC).Methods: A single-institution retrospective chart review was performed on all…
  • 2017 American Transplant Congress

    The Impact of the Kidney Allocation System on Outcomes for Kidneys with KDPI > 85%.

    A. Perry,1 J. Sageshima,1 C. Santhanakrishnan,1 J. McVicar,1 C. Troppmann,1 A. De Mattos,2 J. Woloszyn,1 R. Perez.1

    1Division of Transplant Surgery, University of California, Davis, Sacramento, CA; 2Division of Transplant Medicine, University of California, Davis, Sacramento, CA

    Single center outcomes were examined to assess the impact of the implementation of the Kidney Allocation System (KAS) on outcomes for kidneys with KDPI >85%.Methods:…
  • 2017 American Transplant Congress

    Zero-Time Biopsy of Potential Donor Kidneys to Aid Decision-Making: A 9-Year Single-Center Experience.

    Y. Luque, O. Aubert, F. Martinez, L. Amrouche, C. Tinel, L. Galmiche, L.-H. Noel, J.-P. Duong, F. Audenet, C. Legendre, D. Anglicheau, M. Rabant.

    Necker-Enfants Malades, Tenon and European Georges Pompidou Hospitals, Paris, France

    The added benefits of zero-time biopsy of a potential donor kidney on top of standard donor biological and clinical data to aid in the decision…
  • 2017 American Transplant Congress

    The Role of Urinary Chemokines in Distinguishing Causes of Renal Allograft Dysfunction.

    S. Chong,1 R. Fernando,2 M. Harber,1 C. Magee.1

    1UCL Centre for Nephrology, Royal Free Hospital, London, United Kingdom; 2Anthony Nolan Laboratories, Royal Free Hospital, London, United Kingdom

    The aetiology of renal transplant dysfunction is varied, and diagnosis often relies upon transplant biopsy, an invasive procedure that carries significant risk. Availability of a…
  • 2017 American Transplant Congress

    Short-Term Combination Treatment of FK506 and Anti-CD40 Ligand Remarkably Prolong Allograft Survival Time in Mouse Skin Transplantation.

    X. Zhang, Z. Ding, M. Yang, Y. Miao, Y. Yang, P. Zhou.

    Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Key Laboratory of Organ Transplantation, Ministry of Education; Key Laboratory of Organ Transplantation, Ministry of Health, Wuhan,

    Background: It is well established that skin are more prone than kidney to rejection after transplantation and is difficult to archive allograft acceptance following normal…
  • 2017 American Transplant Congress

    How to Promote Regeneration After Ischemic Reperfusion Injury: Dual Role of CD 137 Agonistic Antibody.

    J. Lee,1,3 H. Kim,3 H. Chung,1 K. Park,1 B. Kwon,3,4 H. Cho.2,3

    1Internal Medicine, Ulsan University Hospital and College of Medicine, University of Ulsan, Ulsan, Korea; 2Surgery, Ulsan University Hospital and College of Medicine, University, Ulsan, Korea; 3Biomedical Research Center, Ulsan University Hospital, Ulsan, Korea; 4School of Biological Science, University of Ulsan, Ulsan, Korea

    Acute sterile inflammation can be induced by tissue damage caused by ischemia-reperfusion. In transplantation ischemia reperfusion injury (IRI) is unavoidable procedure. IRI causes delayed graft…
  • 2017 American Transplant Congress

    Risk Factors for Hospital Readmission with Urinary Tract Infections (UTIs) Following Kidney Transplantation (KT).

    E. Minja, S. Jackson, A. Matas.

    Surgery, UMN, Mpls, MN

    UTIs are common causes of hospital readmissions after KT. Our objective is to determine predictors of hospital readmissions for UTI within 1 year after a…
  • 2017 American Transplant Congress

    Kinetic Estimation of Glomerular Filtration Rate and Urine Creatinine as Predictors of Delayed Graft Function in Kidney Transplantation from Non-Heart Beating Donors.

    M. Calvo, M. Moreno De La Higuera, V. Lopez De La Manzanara, A. Shabaka, M. Poma, I. Perez-Flores, N. Calvo Romero, B. Rodríguez-Cubillo, A. Sanchez-Fructuoso.

    Nephrology, Hospital Clínico San Carlos, Madrid, Spain

    Predicting the occurrence of delayed graft function (DGF) and its duration can facilitate the management of patients after kidney transplantation (KT). Methods: A retrospective study…
  • « Previous Page
  • 1
  • …
  • 127
  • 128
  • 129
  • 130
  • 131
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences